Largest generics company in Romania, Terapia Ranbaxy registered in Q2 of 2008 sales of $ 31,000,000, marking an increase of 5% over the same period the previous year and 17% over first quarter 2008 , signaling the positive impact of prescription brand introduced in early April.
Ranbaxy Laboratories Limited is an international pharmaceutical company integrated, research-based company headquartered in India. It produces a wide range of quality generic and affordable so deeply appreciated by the medical community and by patients in different parts of the world. Standing by Ranbaxy emphasis placed on research and development has led both to obtain approval for marketing of drugs in different markets and significant progress in research and development of new products. Company’s foray in Drug Development Systems in November led to the creation of platform technologies that have generated a number of products under development. The company serves customers in over 125 countries and has an extensive portfolio of subsidiaries, branches and alliances, local operations in 49 countries and manufacturing operations in 9 countries.
